BeiGene Ltd. ADR (BGNE) Social Stream
BEIGENE LTD (BGNE) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BGNE.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 5 | $431 | $343.3 | $404.46 | $187.78 | 115.39% |
| 2022-01-06 | 6 | $431 | $283.3 | $392.46 | $187.78 | 109% |
| 2022-01-12 | 6 | $431 | $283.3 | $388.716 | $187.78 | 107.01% |
| 2022-01-18 | 6 | $431 | $283.3 | $380.883 | $187.78 | 102.83% |
| 2022-01-28 | 6 | $431 | $283.3 | $367.55 | $187.78 | 95.73% |
| 2022-02-08 | 6 | $431 | $283.3 | $354.216 | $187.78 | 88.63% |
| 2022-02-25 | 6 | $431 | $283.3 | $348.55 | $187.78 | 85.62% |
| 2022-02-28 | 6 | $431 | $254 | $332.333 | $187.78 | 76.98% |
| 2022-03-17 | 6 | $431 | $177 | $300.2 | $187.78 | 59.87% |
| 2022-04-28 | 6 | $431 | $177 | $313.166 | $187.78 | 66.77% |
| 2022-05-06 | 6 | $431 | $177 | $296.166 | $187.78 | 57.72% |
| 2022-05-18 | 6 | $431 | $177 | $289.833 | $187.78 | 54.35% |
| 2022-07-27 | 6 | $431 | $177 | $288.666 | $187.78 | 53.73% |
| 2022-08-05 | 6 | $431 | $177 | $284.316 | $187.78 | 51.41% |
| 2022-08-09 | 6 | $431 | $177 | $271.983 | $187.78 | 44.84% |
| 2022-09-17 | 6 | $431 | $177 | $270.6 | $187.78 | 44.1% |
| 2022-10-03 | 6 | $431 | $177 | $269.433 | $187.78 | 43.48% |
| 2022-10-13 | 6 | $296 | $200 | $236.433 | $187.78 | 25.91% |
| 2022-11-14 | 6 | $296 | $205 | $240.266 | $187.78 | 27.95% |
| 2022-12-12 | 7 | $296 | $205 | $244.6 | $187.78 | 30.26% |
| 2022-12-15 | 6 | $302 | $205 | $245.6 | $187.78 | 30.79% |
| 2023-01-19 | 6 | $302 | $205 | $256.266 | $187.78 | 36.47% |
| 2023-01-24 | 6 | $325 | $205 | $261.266 | $187.78 | 39.13% |
| 2023-02-07 | 7 | $325 | $205 | $261.266 | $187.78 | 39.13% |
| 2023-02-20 | 7 | $325 | $205 | $266.316 | $187.78 | 41.82% |
| 2023-02-28 | 7 | $321 | $205 | $261.85 | $187.78 | 39.45% |
| 2023-04-12 | 7 | $350 | $230.1 | $293.35 | $187.78 | 56.22% |
| 2023-04-25 | 6 | $350 | $262 | $298.883 | $187.78 | 59.17% |
| 2023-05-05 | 6 | $350 | $263.3 | $305.883 | $187.78 | 62.89% |
| 2023-05-09 | 6 | $350 | $263.3 | $306.55 | $187.78 | 63.25% |
| 2023-06-26 | 6 | $350 | $257 | $299.383 | $187.78 | 59.43% |
| 2023-06-30 | 7 | $350 | $196 | $284.614 | $187.78 | 51.57% |
| 2023-07-12 | 7 | $350 | $196 | $279.214 | $187.78 | 48.69% |
| 2023-07-17 | 8 | $350 | $196 | $278.687 | $187.78 | 48.41% |
| 2023-08-03 | 8 | $350 | $196 | $276.025 | $187.78 | 46.99% |
| 2023-08-04 | 8 | $350 | $196 | $277.275 | $187.78 | 47.66% |
| 2023-08-07 | 8 | $350 | $196 | $277.15 | $187.78 | 47.59% |
| 2023-08-17 | 9 | $350 | $196 | $278.244 | $187.78 | 48.18% |
| 2023-09-06 | 8 | $350 | $196 | $275.275 | $187.78 | 46.59% |
| 2023-09-12 | 9 | $350 | $196 | $275.677 | $187.78 | 46.81% |
| 2023-09-20 | 9 | $350 | $196 | $273.888 | $187.78 | 45.86% |
The Trend in the Analyst Price Target
Over the past 40 months, BGNE's average price target has gone up $83.66.
BGNE reports an average of 31.68% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-12-15 | 6 | 302 | 205.0 | 245.600 | 207.92 | 18.12% |
| 2023-02-28 | 7 | 350 | 230.1 | 294.183 | 224.63 | 30.96% |
| 2023-06-26 | 6 | 350 | 257.0 | 299.383 | 180.09 | 66.24% |
| 2023-08-03 | 8 | 350 | 196.0 | 276.025 | 205.82 | 34.11% |
| 2023-08-17 | 8 | 350 | 196.0 | 275.525 | 192.28 | 43.29% |
BGNE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.44 | 7 | 0 | 2 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
Over the past 14 months, BGNE's average broker recommendation rating improved by 0.33.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BGNE as an investment opportunity.
- BEIGENE LTD's average analyst price target is higher than 4909.47% of all US stocks.
- BEIGENE LTD's number of analysts covering the stock is greater than 525.32% of stocks in the large market cap category.
- BEIGENE LTD's upside potential (average analyst target price relative to current price) is greater than 3832.76% of stocks in the large market cap category.
- In the context of Pharmaceutical Products stocks, BEIGENE LTD's variance in analysts' estimates is lower than -1661.7% of them.
In the Pharmaceutical Products industry, GLPG, RARE, and ALKS are the three stocks most similar to BEIGENE LTD regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is BGNE a Buy, Hold or Sell? See the POWR Ratings now!